carbidopa has been researched along with Spinal Cord Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carleton, B; Horvath, GA; Meisner, L; Selby, K; Stowe, R | 1 |
Chase, TN | 1 |
1 review(s) available for carbidopa and Spinal Cord Diseases
Article | Year |
---|---|
Serotonergic mechanisms and extrapyramidal function in man.
Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extrapyramidal Tracts; Fenclonine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Imipramine; Levodopa; Muscular Diseases; Paralysis; Parkinson Disease; Parkinson Disease, Secondary; Probenecid; Reserpine; Serotonin; Spinal Cord Diseases; Tetrabenazine; Time Factors | 1974 |
1 other study(ies) available for carbidopa and Spinal Cord Diseases
Article | Year |
---|---|
Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy.
Topics: 5-Hydroxytryptophan; Adult; Atrophy; Carbidopa; Central Nervous System Agents; Fatal Outcome; Female; Humans; Paraparesis; Pregnancy; Pregnancy Complications; Spinal Cord Diseases; Young Adult | 2017 |